PubMed COVID-19 Clinical Care

CONCLUSIONS: These findings suggest that the inconsistency of previous studies in PA change during the pandemic may at least partly be explained by differences in the sociodemographic characteristics of the participants.

No abstract

The coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19), is well-known for its respiratory symptoms. The scientific community and frontline health care providers have been documenting a number of systemic

CONCLUSIONS: Post-COVID symptom clustering provides direction for research into the etiology, diagnosis, and management of post-COVID condition. Studies reporting post-COVID symptom clusters remain rare due to focus on individual symptoms reporting

New HIV infections and AIDS-related deaths among children and adolescent girls and young women (aged 15-24 years) in eastern and southern Africa continue to occur at unacceptably high rates. The COVID-19 pandemic has also severely undermined ongoing

The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in

Systemic corticosteroid is considered effective in treating severe or critical coronavirus disease 2019 (COVID-19) patients in both Chinese and international consensus and/or guidelines. Dexamethasone (6 mg daily for up to 10 days) is usually

Now in the post-pandemic era, healthcare employers and leaders must navigate decisions around use of telework arrangements made popular during the COVID-19 pandemic. Among healthcare employees who teleworked during the pandemic, this study

Tuberculosis is a major health issue globally and a leading cause of death due to the infective microorganism Mycobacterium tuberculosis. Treatment of drug resistance tuberculosis requires longer treatment with multiple daily doses of drugs

CONCLUSION: There was a high prevalence of self-reported COVID-19 risk. Identified communities with COVID-19 high-risk burden in the risk mapping and those with stratified proximity to these areas need to be targeted by the government for a public